Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traumeel S for Post-operative Pain in Hip Fracture
NCT00307905Phase 3Withdrawn
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jan 2011
- Primary completion
- Jun 2012
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Traumeel S with Placebo (2 arms). Primary endpoint: Cumulative 48-hour postoperative morphine consumption. Planned start Jan 2011; status: withdrawn.
02
Drugs
Traumeel S
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00307905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307905.